BioWorld

June 6, 2003

View Archived Issues

Millennium Trimming Operations, Staff As Focus Turns To Profits

In announcing a plan to restructure its organization, Millennium Pharmaceuticals Inc. said its goal is to focus on the commercially attractive items in its pipeline and to reach profitability by 2006. (BioWorld Today) Read More

NPS, Enzon End Merger Plans After Failing To Come To Terms

Read More

Rare, Unplumbable Contortions Of Dual Sézary Syndrome Malignancy Launch Therapeutic Clinical Trials

Read More

Discovery Labs' Surfaxin Support Trial Provides Positive Early Data

Read More

Isis, Lilly Rework Agreement For Affinitak Manufacturing

Read More

Other News To Note

Read More